# Assessment of Subject Use of the Rebiject II Injection Device According to Nurse Examination of Subject Accuracy in 10 Steps as a Dummy Demonstration

> **NCT01195857** · — · COMPLETED · sponsor: **Merck KGaA, Darmstadt, Germany** · enrollment: 100 (actual)

## Conditions studied

- Multiple Sclerosis

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01195857
- **Lead sponsor:** Merck KGaA, Darmstadt, Germany
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2009-01
- **Primary completion:** 2009-09
- **Final completion:** 2009-09
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2014-02-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01195857

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01195857, "Assessment of Subject Use of the Rebiject II Injection Device According to Nurse Examination of Subject Accuracy in 10 Steps as a Dummy Demonstration". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT01195857. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*